This study was conducted to investigate possible genotoxic effects resulting from occupational exposure to indium compounds. We performed a cytogenetic analysis of peripheral blood lymphocytes gathered from 57 individuals exposed to indium at an indium ingot production plant in Guangxi, China, and compared the results with those obtained from 63 control subjects. The lymphocytes from both groups were examined in the chromosomal aberrations (CAs) assay, cytokinesis-block micronucleus (CBMN) assay, and single-cell gel electrophoresis (comet) assay. Samples of personal breathing zone air were collected throughout the work shift of each subject. Blood and urine samples were collected before and after each work shift on the same day as the air samples were collected. Our assay results showed that workers in the indium production plant were exposed to significantly higher levels of indium (median exposure, 8.00 lg/m 3 ) than the control subjects. Also, higher concentrations of urinary indium (U-In) were found in the exposed workers than the control subjects. When compared with the control subjects, the exposed workers showed higher levels of DNA damage as detected by the comet assay (tail length and TDNA%), significantly higher frequencies of CAs/100 cells, and increased CBMN frequencies. Moreover, the mean CBMN frequency in the non-smokers exposed to indium was significantly higher than that in the non-smoker control subjects (3.14 vs 1.00, respectively; P < .01). U-In levels, comet assay, CBMN, and CA test proved to be the most sensitive biological markers for detecting occupational exposure to indium compounds and can also be used to assess the health risks of the exposed workers.
disease have been in Japan, the United States, and China (Cummings et al., 2010; Cummings et al., 2012; Homma et al., 2005; Sungyeul et al., 2013; Xiao et al., 2010) . The interstitial and emphysematous lung damage incurred by workers exposed to indium compounds is referred to as "Indium Lung" (Omae et al., 2011) . Despite evidence for the harmful respiratory effects produced by indium compounds, no study has investigated the incidence of indium-induced genotoxicity in China. Therefore, this study was performed to determine whether there is a relationship between exposure to indium compounds and genetic aberrations observed in workers occupationally exposed to indium compounds in China.
To address this issue, we detected cytogenetic abnormalities present in the lymphocytes of workers at the high purity indium manufacturing plant located in Guangxi, China. The abnormalities were identified by chromosome aberration analysis and the micronuclei test. We also quantitatively analyzed DNA damage using the comet assay. The comet assay may be a rapid and sensitive technique suitable for monitoring humans in vivo and especially humans continuously exposed to genotoxic chemicals. The CBMN assay is a method for assessing DNA damage caused by xenobiotics and can be used to detect the effects of clastogenic and aneugenic agents (Fenech, 2000) . Due to its high reliability and reproducibility, the CBMN assay has become a standard cytogenetic test used to detect genetic damage in human and mammalian cells. Another method for assessing genetic damage is the chromosomal aberrations (CAs) test. This test has been widely used for a long time to evaluate the effects of exposure to a mutagen or carcinogen. The results of this current study provide the first data obtained in China regarding the genotoxic hazards associated with indium exposure. Additionally, our data can be used to assess the feasibility of using biomarkers to evaluate potential occupational health risks.
MATERIALS AND METHODS

Subjects
The protocol for this study was approved by the Research Ethics Committee of the North China University of Science and Technology. The study was conducted in an indium ingot production plant (Guangxi, China) where 57 workers are mainly exposed to indium metal, but also to In 2 SO 4 , In 2 O 3, and to a lesser extent, indium chloride [InCl 3 ]. The control subjects were 63 workers who had no history of occupational exposure to indium, and were matched with the exposed workers for age, sex, and smoking habits. Individuals who had been smoking for > 3 months were considered smokers and those who had consumed alcohol more than twice a week during the previous 6 months were defined as drinkers.
All study participants were interviewed by an occupational health physician who used a detailed questionnaire to obtain demographic information, as well as information concerning the subject's current and previous jobs, educational level, smoking history, alcohol consumption, occupational history of exposure, personal medical history, history of exposure to ionizing radiation during the previous 12 months, and possible exposure to non-occupational sources of indium. The study exclusion criteria included recent treatments with mutagenic agents (such as X-rays), chronic conditions (such as an autoimmune disease), recent acute infections that required treatment with medications such as antibiotics, and refusal to sign the consent form.
Workplace Air Sampling
Based on the indium production process, the workshop was divided into four separate workplaces; these included workplaces used for (a) indium slag leaching, extraction, and electrolytic processing (b) indium replacement, (c) indium volatile kiln dust collection, and (d) the indium furnace post. When studying the 57 workers exposed to indium, two of the air-monitoring badges in each of the five workplaces were used as blank control badges during the production periods. Workplace environmental exposure to airborne indium was monitored throughout the work shifts of both the exposed workers and control subjects. Air in the breathing zones was drawn at flow rates of 1.5-3 L/min during the work periods, which ranged from 6 to 8 h. Workers who wore the personal sampling devices were asked to record the contents of their jobs during the work periods. After sampling, the collected samples were preserved at 4 C until the time of analysis. All analyses were performed in a blinded manner, and the results were confirmed by replication on the following day.
In our dynamic study of the 57 workers, we determined the indium exposure levels of workers doing different types of jobs, including (a) workshop driver, (b) workshop manager, (c) lab technician, (d) workshop electrician, (e) warehouse keeper, (f) indium electrolytic worker, (g) indium feed worker, and (h) operator.
A standard solution of indium was prepared; after which, appropriate dilutions were used to construct a standard curve for use in determining indium concentrations, which were detected by inductively coupled argon plasma mass spectrometry. Airborne indium was measured by ICP-MS, with the estimated lower detection limit being 0.045 lg/m 3 . This estimate is $10% of the acceptable indium exposure limit of 0.3 lg/m 3 .
Urine Sampling
On the day of air sampling, spot urine samples were obtained from each subject at the end of a work shift for at least five consecutive days of work. Each urine sample was divided into two aliquots. One 10 mL aliquot was frozen at À20 C; after which, it was later thawed and used to determine the worker's urinary creatinine level. The second 10 mL aliquot was immediately transferred into a pre-sealed 20 mL clean polypropylene bottle containing 1% HNO 3 and preserved at 4 C until being assayed for its indium concentration. All analyses were conducted in blinded manner. Urinary indium (U-In) concentrations were determined by ICP-MS performed with an Agilent 7500 mass spectrometer (Agilent Technologies; Santa Clara, CA, USA). When using this method, the LOD for indium as estimated by calculating the standard error of the intercept on the calibration curve, was 0.03 lg/L.
Chromosomal Aberrations Test
A sample of peripheral blood was obtained from each subject immediately prior to the start of urine spot sampling. After being coded, the blood samples were transported to a laboratory where they were cultured for cytogenetic tests within 72 h of collection. When performing the CA assay, 0.4 mL of whole blood was incubated in a 5 mL solution containing 78% RPMI 1640, 20% inactivated fetal bovine serum, 100 U/mL penicillin, 100 lg/mL streptomycin, and stimulated 2% phytohemagglutinin. All cultures were then incubated at 37 C for 72 h, and cell division was interrupted by addition of colcemid (0.2 lg/mL) after 68 h of incubation. The cells were then harvested by centrifugation, suspended in a hypotonic 0.075 M KCl solution, and fixed in methanol:acetic acid solution. At least 200 metaphases/ individual were counted on coded slides and scored in blinded manner according to the International System for Human Cytogenetic Nomenclature for CA (Zakeri et al., 2010) . The individual who scored the slides was blinded to the exposure status of the 120 study participants. The endpoints analyzed were mitotic index (MI) and the total number of chromosomal aberrations, which included chromatid gaps, chromatid and chromosome breaks, and dicentric chromosomes. MI was determined by scoring the number of metaphases in 1000 cells per culture. Aberrations were classified according to ISCN Specifications (1985) .
Micronucleus Test
The CBMN test was used to detect chromosome damage and was performed using a method previously described (Fenech 2000) . In brief, 0.4 mL of whole blood was cultured and stimulated with PHA for 44 h. Next, cytochalasin B was added to the culture at a final concentration of 6 mg/mL; after which, the cells were harvested. Two different cell cultures were established for each subject. Finally, the cultured cells were harvested by centrifugation, washed, and fixed with acetic acid:methanol solution (75:25, v/v). After spreading the cell suspension onto glass slides, the cells were stained with 10% Giemsa solution and counted under a light microscope. For each subject, 1000 binucleated lymphocytes in each sample were randomly examined and scored by trained staff that applied the same criteria in a blinded fashion. Results are expressed as the CBMN frequency per 1000 binucleated cells. As a measure of cytotoxicity, the cytokinesis-block proliferating index (CBPI) was calculated according to Surralles et al. (1995) and using the following formula: CBPI ¼ (number of mononucleate cells þ 2 Â number of binucleate cells þ 3 Â number of polynucleate cells)/total number of cells.
Comet Assay
The comet assay was performed under neutral conditions and using a previously described method (Da Silva et al., 2008; Grethel et al., 2011) . One-hundred randomly selected comets were analyzed for each individual. Image analysis software was used to analyze the images, and damage to lymphocyte DNA was quantified based on the comet's tail length and the percentage of DNA in the comet's tail (TDNA%) [Comet tail length (lm) ¼ (total length of comet and head) À (head diameter)]. All experiments were performed in duplicate. The mean values for all comet assay parameters were taken into account when performing our final statistical analysis. Image analysis was performed using comet image analysis software IMI1.0, developed in China.
Statistical Analyses
All statistical analyses were performed using SPSS 17.0 software. The data for U-In levels, CAs, and CBMN frequency displayed an approximate log-normal distribution, and thus their ln-transformed values were used for analysis. The KolmogorovSmirnov test was used to assess the normal distribution of all variables. The v 2 test was used to compare the frequencies of current smokers and alcohol users and differences between the educational levels of those two study groups. The v 2 test was also used to detect whether an allelic distribution displayed Hardy-Weinberg equilibrium. Spearman's rank correlation test was used to evaluate the relationship between U-In levels and MN frequencies. P-values < .05 were considered statistically significant. ). The mean indium exposure of the 57 workers was 78.41 6 65.22 lg/m 3 (mean 6 SE). No biological sample gathered from the control group had a quantifiable level of indium, whereas no biological sample gathered from the exposed group had an indium concentration below the LOQ.
RESULTS
Ambient Indium Concentrations
General Characteristics of the Study Population
Some general characteristics of the subjects in the control group (n ¼ 63) and indium exposure group (n ¼ 57) are summarized in Table 2 . The two groups showed no significance differences in age, sex distribution or smoking and drinking habits.
Biomarkers of the Urine Indium Concentration
The mean concentration of indium in the urine (U-In) of the exposed group was 9.24 ng/L (Table 3 ). The corresponding value adjusted for urinary creatinine concentration (U-In creat ) was 11.00 ng/g Cr. U-In values were strongly correlated with U-In creat values (r ¼ 0.791, P < .001). No statistically significant correlation was found between the in-air and biological levels of indium.
Chromosomal Aberration Analysis
The MIs and frequencies of chromosomal aberrations in the control group and indium-exposed group were obtained by cytogenetic analysis. Chromatid gaps and breaks were the most frequent type of aberration observed in both groups, followed by complex exchanges (dicentric chromosomes and chromosome breaks; Table 4 ). No significant differences were observed between the MIs of the indium-exposed individuals and control subjects (P > .05). Statistically significant difference in comparison with non-smokers exposed and smokers controls(P < .01). The frequency of chromosomal aberrations/100 cells in both study groups was obtained by cytogenetic analysis. Table 4 and Figure 1 show the frequency of CAs in the two study groups. This comparison clearly shows that there were higher CA frequencies in the indium-exposed group (0.15/100 cells) when compared with the non-exposed control group (0.06/100 cells). Moreover, this difference between groups was statistically significant when evaluated by the Mann-Whitney U-test (P < .01). The frequency of chromosomal damage found among smokers in the indium-exposed group (0.14/100 cells) was significantly (P < .01) higher than that found among both smokers (0.06/100 cells, P < .01) and non-smokers (0.05/100 cells, P < .01) in the control group. The aberration frequencies among indiumexposed non-smokers and smokers were 0.15 and 0.14, respectively (Table 4) , and thus not significantly different (P > .05).
Micronucleus Test
The micronucleus frequency values for both study groups are summarized in Table 5 . The mean micronuclei/1000 binucleated cells found among the peripheral lymphocytes of exposed workers (3.67) were significantly higher than that found among the peripheral lymphocytes of control subjects (1.17; P < .01). In the present study, the CBMN rate in each group was fully concordant with the CA frequency as determined by chromosome aberration analysis. To study the relationship between cigarette-smoking and the genotoxic effects of biomarkers, all subjects, regardless of their group, were subdivided into the categories of smokers and non-smokers (Table 5 ). The subjects in the two categories were matched for age and gender. A subsequent analysis showed that the frequency of CBMN was significantly higher in the non-smoker iridium-exposed group than in the non-smoker control group 3.14 versus 1.00, respectively (P < .05). Furthermore, the frequency of CBMN was also higher in the smoker iridium-exposed group than in the smoker control group (4.57 vs 1.35, respectively). An analysis of the CBPI as a measure of cytotoxicity showed no significant difference between the control group and the indium-exposed group (1.37 vs 1.29, respectively). Additionally, we identified a positive correlation between U-In, U-In creat , and the frequency of CBMN/ 1000 cells (r ¼ 0.311, P < .01; Figs. 2 and 3) . Figure 4 shows In-induced DNA damage to lymphocytes. The comet assay is a sensitive method for evaluating DNA damage, and its mean values for parameters in the two study groups are shown in Table 6 . The values for comet tail length and TDNA% among the exposed workers were much higher than those for individuals in the non-exposed group (P < 0.001). These results clearly demonstrate that the level of DNA damage in the indium-exposed group (tail length ¼ 16.36 6 7.56; TDNA% ¼ 5.01 6 3.08) was much higher than that in the nonexposed group (tail length ¼ 10.80 6 5.63; TDNA% ¼ 2.69 6 1.61). Both of these differences between groups (tail length and TDNA%) were statistically significant when evaluated with the Mann-Whitney U-test.
Comet Assay
Effect of Exposure Time to Indium Compounds and the Type of Work Performed with the Compounds
We also examined how confounding factors such as work area activities and an individual's duration of exposure to indium compounds might affect the levels of DNA damage and frequencies of CBMN and CAs. Both biomarkers showed significantly higher values in the indium-exposed group when compared with the non-exposed control group. Among the exposed workers, significant increases in CBMN frequency, CA frequency, DNA damage (tail length and TDNA%) and U-In creat were observed when the duration of indium exposure exceeded 6 years (P > .05). (Table 7) . For the exposed workers, an significant increase in CBMN frequency, DNA damage (tail length) and U-In creat were also observed when workers in the four separate workplaces (P > .05). (Table 8 ).These results indicate that exposure to indium and indium-containing compounds may produce genotoxic effects in among indium workers.
DISCUSSION
During the indium production process, our personalized air sampling data showed that workers were exposed to a median indium concentration of 8.00 lg/m 3 . This level of occupational exposure to indium is comparable to the exposures reported by several authors who monitored similar groups of workers in Western countries (Hiroyuki et al., 2012; Perrine et al., 2012) . Most of our control subjects were not exposed to indium at levels > 0.1 lg/m 3 . Although we explored a possible relationship between the current concentrations of airborne In and the value for U-In or U-In creat , no significant relationship was found, indicating that these indices do not reflect recent exposure. However, this absence of a relationship might be partially due to the relatively small sample size and the duration of exposure being underestimated. Most published studies have focused on the pulmonary toxicities of inhaled indium containing materials (eg, indium phosphide and indium arsenide) in animals and humans, while the genotoxic effects of such compounds have only been evaluated in rodent populations (Takagi et al., 2011) . This study mainly focused on the genotoxic effects of indium compounds and especially the effects of indium sulfate (In 2 SO 4 ), indium oxide (In 2 O 3 ), metallic In, and to a certain extent, indium chloride [InCl 3 ] on the workers who handle these materials in the workplace. Our results can be used for making recommendations that will reduce or prevent exposure to indium compounds in the workplace. Biological monitoring, including the monitoring of different biomarkers of exposure, effect, or susceptibility, has a fundamental role in performing occupational risk assessments (Manno et al., 2010) . Cytogenetic markers such as CAs, CBMN, and sister chromatid exchanges (SCEs) can be rapidly assessed, and are sensitive indicators of genetic damage. In the present study, we used the comet assay, micronuclei test, and chromosome aberration analysis to detect cytogenetic changes which had occurred in peripheral blood lymphocytes obtained from indium-exposed workers and non-exposed individuals. Due to the complex mixtures used for manufacturing indium-containing compounds, it is difficult to relate a specific genotoxic effect to a particular element or compound. In this study, we used the comet assay to detect the extent of primary DNA damage and the CA and CBMN tests to detect cytogenic biomarkers of genetic damage in peripheral blood lymphocytes obtained from indium-exposed and non-exposed individuals. Our results from comet assays, CA analyses, and CBMN tests indicated that the peripheral blood lymphocytes from a group of workers exposed to indium compounds had sustained significantly higher levels of DNA damage than the peripheral lymphocytes obtained from a group of nonexposed control individuals (P < .001). The comet assay is particularly sensitive in detecting direct and indirect DNA strand breakage and DNA alkaline-labile sites. These types of DNA damage are usually produced by genotoxic agents that induce breaks in the phosphodiester skeleton of DNA or between its base and sugar residues, resulting in abasic sites (Tice et al., 2000) . The CBMN test is extensively used in biomonitoring and molecular epidemiology studies to evaluate the presence and extent of chromosomal damage in lymphocytes obtained from human populations exposed to genotoxic agents. Moreover, an increased CBMN frequency has been validated as a cancer risk biomarker in humans (Bonassi et al., 2007; Fenech et al., 1999) . The scoring of micronuclei in peripheral blood lymphocytes is an easy and rapid method for assessing cytogenetic damage.
We found positive correlations between the frequency of CBMN/1000 cells and the internal level of creatinine in urine (U-In creat ). Higher U-In concentrations were found in indiumexposed workers (range 0.07-54.93 ng/L; 0.17-58.10 ng/g creat) than in control subjects (range 0.01-8.61 ng/L; 0.01-8.38 ng/g creat), indicating that urine indium levels can be used as a biomarker for the internal dose of indium resulting from occupational exposure. Thus we suggest that occupational exposure to indium compounds induces DNA damage at the chromosomal level. Our results showed that the genotoxic effects of indium exposure can be detected by the comet assay, CA analysis, and the CBMN test. Moreover, concentrations of indium in urine can be used to assess the occupational exposure to indium and indium-containing compounds. A reduced workload is necessary to decrease the occupational exposure of workers to indium, and the associated health hazards.
In conclusion, this is the first study to simultaneously assess the DNA damage (tail length and TDNA%) and frequency of CAs and CBMN in peripheral lymphocytes obtained from subjects exposed to indium compounds in China. Our results may motivate companies that manufacture indium-containing products to monitor biomarkers of genetic damage and implement strategies for reducing occupational exposure to indium in their facilities located in developing countries. The increased DNA damage and frequencies of CAs and MN found in indiumexposed workers indicate that occupational exposure to indium results in genetic changes that may play a role in indiuminduced carcinogenesis and genetic diseases. Nevertheless, further studies are needed to clarify the possible correlation between exposure to indium compounds and the frequency of CAs and CBMN, as well as the factors that might affect this correlation. Our results also show that further technological and organizational measures need to be taken to ensure the occupational safety of indium workers and further protect their health by reducing their occupational exposure to indium.
ACKNOWLEDGMENTS
We wish to acknowledge Fuyuan Cao for providing technical assistance. All authors declare they have no competing interests. Significant difference in relation to the non-exposed control group; Kruskall Wallis-Dunn correction P < .01.
FUNDING
This study was supported by "National Public Welfare Health Industry Scientific Research" (No. 201402021).
